Skip to content Skip to footer

Flora Growth Corp. To Chair U.S. Hemp Roundtable Board of Directors

FORT LAUDERDALE, FLORIDA – January 22, 2024 – Flora Growth Corp. (NASDAQ: FLGC) (“Flora” or the “Company”), a consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000+ points of distribution around the world, is pleased to announce that Clifford Starke, the Company’s Chief Executive Officer and Director, has been elected as Chairman of the U.S. Hemp Roundtable Board of Directors.

“Given the current political environment, momentum is swinging in the right direction. We, at Flora, seek to be at the forefront of advancement and innovation to make hemp and cannabis legally accessible to everyone,” said Clifford Starke, Chief Executive Officer.

“We’re pleased to announce the election of Mr. Clifford Starke as the Chairman of the Board of Directors of the U.S. Hemp Roundtable,” said U.S. Hemp Roundtable General Counsel, Jonathan Miller. “Flora Growth has been an outstanding board member of the Roundtable, and we are excited to have Mr. Starke step up to play a leadership role in a critical year ahead for the industry. We extend our heartfelt gratitude to Mr. Starke for his unwavering support and commitment to advancing the U.S. hemp sector.”


About U.S. Hemp Roundtable

The U.S. Hemp Roundtable is the hemp industry’s national advocacy organization, a coalition of dozens of leading companies and organizations committed to safe hemp and CBD products. The Roundtable proudly works in partnership with the industry’s leading national, regional and state grassroots organizations, and is leading the way forward for hemp and CBD products through education and action. More at

About Flora Growth Corp.
Flora Growth Corp. is a consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000+ points of distribution around the world. For more information on Flora, visit

Investor Relations:
Investor Relations
Clifford Starke


Cautionary Statement Concerning Forward­ Looking Statements

This press release contains “forward looking statements,” as defined by federal securities laws. Forward-looking statements reflect Flora’s current expectations and projections about future events at the time, and thus involve uncertainty and risk. The words “believe,” “expect,” “anticipate,” “will,” “could,” “would,” “should,” “may,” “plan,” “estimate,” “intend,” “predict,” “potential,” “continue,” and the negatives of these words and other similar expressions generally identify forward looking statements. Such forward looking statements are subject to various and risks and uncertainties, including those described under section entitled “Risk Factors” in Flora’s Annual Report on Form 10K filed with the United States Securities and Exchange Commission (the “SEC”) on March 31, 2023, as such factors may be updated from time to time in Flora’s periodic filings with the SEC, which are accessible on the SEC’s website at Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this release and in Flora’s filings with the SEC. While forward looking statements reflect Flora’s good faith beliefs, they are not guarantees of future performance. Flora disclaims any obligation to publicly update or revise any forward-looking statement to reflect changes in underlying assumptions or factors, new information, data or methods, future events or other changes after the date of this press release, except as required by applicable law. You should not place undue reliance on any forward-looking statements, which are based on information currently available to Flora (or to third parties making the forward-looking statements).

Leave a comment